tellmeGen
PrivateLast Round
Accelerator
Jun 1, 2014
Total Funding Raised
$272,000
Company Overview
tellmeGen operates in Healthcare & Life Sciences and is based in Valencia. Its latest recorded funding round was an Accelerator round in June 2014.
tellmeGen is a biotechnology company that provides direct-to-consumer genetic testing services, including health, ancestry, and pharmacogenetic reports.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
tellmeGen Comparables
Compare tellmeGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 24Genetics | 93% | |
| Living DNA | 89% | |
| CRI Genetics | 85% |
For institutional investors. Book with your work email.
tellmeGen Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
tellmeGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanzadera | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Grew 19% QoQ, from 31 to 37 employees.
- Jun 1, 2014
$272K raised from Lanzadera.
For institutional investors. Book with your work email.
tellmeGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about tellmeGen's valuation, stock price, and market status.
Is tellmeGen a public or private company?
tellmeGen is a private company.
What is the current stock price of tellmeGen?
tellmeGen is a private company, so its shares have no public market price. Caplight tracks tellmeGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is tellmeGen worth (valuation)?
Valuation information for tellmeGen is not publicly available.
Can I buy tellmeGen stock?
tellmeGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was tellmeGen's last funding round?
tellmeGen's most recent funding round was Accelerator on June 1, 2014.
Who are the main investors in tellmeGen?
Key investors in tellmeGen include Lanzadera.
Will tellmeGen IPO soon?
No public IPO plans have been announced for tellmeGen.
How can I track tellmeGen secondary market activity?
Caplight tracks bids, offers, and trades in tellmeGen's shares on secondary markets.